Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ADENIS, A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 78

  • Page / 4
Export

Selection :

  • and

Association étoposide, épirubicine et cisplatine (EEP) dans les cancers métastatiques du cardia et de l'estomac = Phase II study with the combination of etoposide, epirubicin and cisplatin in metastatique gastric cancerADENIS, A.Bulletin du cancer. 1994, Vol 81, Num 4, pp 331-333, issn 0007-4551Article

Standards, Options et Recommandations pour la surveillance après traitement d'un cancer du côlon = Standards, Options and Recommendations for the follow-up after treatment for colonic cancerCONROY, T; ADENIS, A.Bulletin du cancer. 1998, Vol 85, Num 2, pp 152-159, issn 0007-4551Article

Diarrhées infectieuses aiguës de l'adulte: mécanismes et aspects thérapeutiques = Acute infectious diarrhea in the adult: mecanism and therapeutic aspectsADENIS, A; COLOMBEL, J. F.NPN médecine. 1986, Vol 6, Num 111-112, pp 333-340, issn 0248-9635, 6 p.Article

Les essais thérapeutiques PRODIGE en cours = PRODIGE ongoing trialsMANFREDI, S; APARICIO, T; ADENIS, A et al.La Lettre du cancérologue (Boulogne). 2012, Vol 21, Num 4, pp 212-215, issn 1165-113X, 4 p.Conference Paper

FOLFIRINOX versus gemcitabine in patients with metastatic pancreatic cancerCONROY, T; DESSEIGNE, F; BENNOUNA, J et al.Cancéro digest. 2011, Vol 3, Num 4, pp 310-312, issn 1953-5171, 3 p.Article

Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results : CyberKnife robotic stereotactic radiosurgeryLOUIS, C; DEWAS, S; MIRABEL, X et al.Technology in cancer research & treatment (Print). 2010, Vol 9, Num 5, pp 479-487, issn 1533-0346, 9 p.Article

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerCONROY, T; YATAGHENE, Y; RIO, E et al.British journal of cancer. 2010, Vol 103, Num 9, pp 1349-1355, issn 0007-0920, 7 p.Article

Phase II trial of chronomodulated infusion of high-dose fluorouracil and I-folinic acid in previously untreated patients with metastatic colorectal cancerCURE, H; CHEVALIER, V; LEVI, F et al.Journal of clinical oncology. 2002, Vol 20, Num 5, pp 1175-1181, issn 0732-183XArticle

Cytarabine and cisplatin as salvage therapy in patients with metastatic colorectal cancer who failed 5-fluorouracil + folinic acid regimenADENIS, A; CARLIER, D; DARLOY, F et al.American journal of clinical oncology. 1995, Vol 18, Num 2, pp 158-160, issn 0277-3732Article

Métastases(s) sans tumeur primitive. La «bonne dose» d'explorations = Metastasis without primitive tumor. The good dose of explorationsVENNIN, P; DELOBELLE, A; LEFEBVRE, J.-L et al.NPN médecine. 1993, Num 206, pp 21-23, issn 0248-9635Article

Ulcérations intestinales au cours d'une maladie cœliaque de l'adulte: intérêt de l'entéroscopie peropératoire = Intestinal ulcerations in an adult with celiac disease. Value of transoperative enteroscopyMESNARD, B; BONNIERE, P; COLOMBEL, J. F et al.La Presse médicale (1983). 1989, Vol 18, Num 16, issn 0755-4982, 847Article

Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabMALKA, D; BOIGE, V; GUICHARD, P et al.Annals of oncology. 2012, Vol 23, Num 4, pp 919-927, issn 0923-7534, 9 p.Article

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancerCONROY, T; HEBBAR, M; DOUILLARD, J. Y et al.British journal of cancer. 2010, Vol 102, Num 1, pp 59-67, issn 0007-0920, 9 p.Article

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinomaDUCREUX, M; ROUGIER, P; ADENIS, A et al.Annals of oncology. 2002, Vol 13, Num 8, pp 1185-1191, issn 0923-7534Article

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalCONROY, T; ETIENNE, P.-L; KOHSER, F et al.Annals of oncology. 2002, Vol 13, Num 5, pp 721-729, issn 0923-7534Article

Devenir des cancers épidermoïdes de l'œsophage en réponse complète après chimio-radiothérapie pré-opératoire = Long-term results of resected esophageal cancer with complete remission to pre-operative chemoradiationTRIBOULET, J. P; AMROUNI, H; GUILLEM, P et al.Annales de chirurgie (Paris). 1998, Vol 52, Num 6, pp 503-508, issn 0003-3944Article

Etude du protocole VMMC (vindésine, mitoxantrone, mitomycine C) comme chimiothérapie de rattrapage dans les cancers du sein évolués = Vindesine, mitoxantrone and mitomycine C Regimen as a salvage treatment for advanced breast cancerDEGARDIN, M; HECQUET, B; BONNETERRE, J et al.Bulletin du cancer. 1992, Vol 79, Num 2, pp 169-176, issn 0007-4551Article

Lasers in rectosigmoid cancers: factors affecting immediate and long-term resultsBRUNETAUD, J. M; MAUNOURY, V; COCHELARD, D et al.Baillière's clinical gastroenterology. 1989, Vol 3, Num 3, pp 615-626, issn 0950-3528Article

Etiologie des atrophies villositaires subtotales et totales = Etiology of total or subtotal villous atrophyADENIS, A; LEROY, M. A; TURCK, D et al.Archives françaises de pédiatrie. 1985, Vol 42, Num 9, issn 0003-9764, 811Article

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trialADENIS, A; BLAY, J.-Y; BLESIUS, A et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1762-1769, issn 0923-7534, 8 p.Article

Les essais thérapeutiques PRODIGE en cours = PRODIGE ongoing trialsMANFREDI, S; APARICIO, T; ADENIS, A et al.La Lettre de l'hépato-gastroentérologue. 2012, Vol 15, Num 2, pp 88-91, issn 1286-580X, 4 p.Conference Paper

Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancerFALLIK, D; YCHOU, M; DUCREUX, M et al.Annals of oncology. 2003, Vol 14, Num 6, pp 856-863, issn 0923-7534, 8 p.Article

Nouveaux agents de chimiothérapie en cancérologie digestive : Acquis et perspectives = New drugs in gastrointestinal oncology. Current status and future directionsCONROY, T; PAILLOT, B; ADENIS, A et al.Gastroentérologie clinique et biologique. 1999, Vol 23, Num 11, pp 1145-1165, issn 0399-8320Article

Results of a phase II trial with second-fine cystemustine at 60 mg/m2 in advanced soft tissue sarcoma : A trial of The EORTC Early Clinical Studies GroupCURE, H; KRAKOWSKI, I; ADENIS, A et al.European journal of cancer (1990). 1998, Vol 34, Num 3, pp 422-423, issn 0959-8049Article

Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX Regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumorsADENIS, A; LERICHE, N; PION, J.-M et al.Anticancer research. 1996, Vol 16, Num 4A, pp 2063-2068, issn 0250-7005, 5 p.Article

  • Page / 4